89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma

Bibliographic Details
Main Authors:	Knight, J, Mosley, M, Bravo, L, Fokas, E, Cornelissen, B
Format:	Conference item
Published:	Society of Nuclear Medicine 2016

Similar Items